Dr. Antonio Calles 🫁🚭· @Tony_Calles · X·· 1 天前评分45
正文 · 原文
#ESMO26 Day+2 is about to start! ⭐️ Ready for the Rapid Orals, NSCLC metástasic #LCSM @myESMO
142 浏览 · 2 赞 · 0 转发 · 0 回复
会议摘要
1017P按 Developmental therapeutics 对上
Phase 1 first-in-human (FIH) results of YL211, a c-Met targeting antibody-drug conjugate (ADC), in patients (pts) with advanced solid tumors
https://esmocongress.esmo.orgNCT06110663NCT06110663按 - **标题 / Title：** A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy 对上
- **标题 / Title：** A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy
https://esmocongress.esmo.org来源：Dr. Antonio Calles 🫁🚭 · x.com